Medical Marijuana Users More Likely To Consume Edibles And Vaporize, RAND Study Finds

People who use marijuana for medical purposes are much more likely to vaporize or consume edible forms of the drug than recreational users, according to a new RAND Corporation study. The study, which surveyed people from four western states that have legalized medical marijuana, also found that those who use…

Continue reading

Study: CBD Oil ‘Highly Promising’ In Pediatric Epilepsy Treatment

By Paul Armentano, NORML Deputy Director The administration of cannabis oil extracts high in cannabidiol reduces seizure frequency in children with intractable epilepsy, according to clinical data published online ahead of print in the journal Seizure. Israeli researchers retrospectively evaluated the effects of CBD oil in a multicenter cohort of…

Continue reading

Study: Vaporizers Deliver Safe And Reliable Doses Of Cannabinoids

By Paul Armentano, NORML Deputy Director Electronically driven vaporizers deliver cannabinoids in a relatively safe and reliable manner, according to data published in the journal PLOS ONE. Swiss investigators evaluated the ability of various types of vaporizer technologies to safely and effectively release THC and CBD (cannabidiol) in vapor. Researchers…

Continue reading

Study: Marijuana Extract Oil Mitigates Symptoms Of Alzheimer’s-Induced Dementia

By Paul Armentano, NORML Deputy Director The administration of liquid cannabis extracts containing THC is associated with the mitigation of various symptoms of Alzheimer’s-related agitation and dementia, according to observational trial data published online ahead of print in The Journal of Alzheimer’s Disease. Israeli investigators assessed the use of cannabis oil…

Continue reading

Study: Alcohol Is The Real Gateway Drug, Not Marijuana

By Paul Armentano, NORML Deputy Director Alcohol is typically the first substance consumed by individuals who report polydrug use later in life, according to data published this month in The Journal of School Health. Researchers from Texas A&M University and the University of Florida, Gainesville evaluated drug use patterns from…

Continue reading

Study: Marijuana Use Not Predictive Of Lower IQ, Poorer Educational Performance

By Paul Armentano, NORML Deputy Director Marijuana use by adolescents is not associated with lower IQ or poorer educational performance once adjustments are made for potential confounders, specifically cigarette smoking, according to longitudinal data published online ahead of print in the Journal of Psychopharmacology. British investigators assessed the relationship between…

Continue reading

Study: Marijuana Use Associated With Decreased Migraine Frequency

By Paul Armentano, NORML Deputy Director Cannabis administration is associated with decreased migraine headache frequency, according to data published online ahead of print in the journal Pharmacotherapy. Investigators at the University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences retrospectively assessed cannabis’ effects on monthly migraine headache frequency in…

Continue reading

Annual Study Shows Marijuana Legalization Not Increasing Teen Use

By Phillip Smith The University of Michigan’s annual Monitoring the Future (MTF) survey of teen drug use was released today and shows that softening attitudes toward marijuana and actual marijuana legalization in four states and Washington, DC, are not translating into increased teen pot smoking. The survey also had generally…

Continue reading

Largest Study Ever On Marijuana And Epilepsy Shows Effectiveness Of Cannabis

Marijuana has been proven to be tremendously effective when it comes to treating epilepsy. It seems like most of the time that I see medical marijuana being talked about on the news or in print media, it’s almost always talking about how CBD can help epilepsy, with countless success stories.…

Continue reading

Study: Cannabinoids Are Safe, Effective For Treating Pain

By Paul Armentano, NORML Deputy Director Cannabinoids are safe and effective for the treatment of chronic pain, according to the results of a systematic review of randomized controlled trials published in the Journal of Neuroimmune Pharmacology. Investigators from Dalhousie University in Halifax, Nova Scotia and McGill University in Montreal evaluated…

Continue reading